14 results on '"Daubioul, Catherine A."'
Search Results
2. Impact of inulin and oligofructose on gastrointestinal peptides
- Author
-
Delzenne, Nathalie M., Cani, Patrice D., Daubioul, Catherine, and Neyrinck, Audrey M.
- Published
- 2005
3. Dietary Oligofructose Lessens Hepatic Steatosis, but Does Not Prevent Hypertriglyceridemia in Obese Zucker Rats
- Author
-
Daubioul, Catherine A., Taper, Henryk S., De Wispelaere, Laurent D., and Delzenne, Nathalie M.
- Published
- 2000
- Full Text
- View/download PDF
4. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study.
- Author
-
UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique, UCL - MD/RAIM - Département de radiologie et d'imagerie médicale, UCL - MD/FARM - Ecole de pharmacie, Daubioul, Catherine, Horsmans, Yves, Lambert, Philippe, Danse, Etienne, Delzenne, Nathalie M., UCL - (SLuc) Service de gastro-entérologie et hépatologie pédiatrique, UCL - MD/RAIM - Département de radiologie et d'imagerie médicale, UCL - MD/FARM - Ecole de pharmacie, Daubioul, Catherine, Horsmans, Yves, Lambert, Philippe, Danse, Etienne, and Delzenne, Nathalie M.
- Abstract
OBJECTIVE: In experimental animals, recent results suggest that the addition of inulin-type fructans such as oligofructose (OFS) in the diet decreases triacylglycerol accumulation in the liver tissue. Therefore, we have investigated the effect of daily ingestion of OFS in seven patients with nonalcoholic steatohepatitis (NASH), confirmed by liver biopsies. DESIGN: They received 16 g/day OFS or maltodextrine (placebo) for 8 weeks in a randomized double-blind crossover design. Energy intake, body composition, liver steatosis and blood parameters were analysed after 4 and 8 weeks of dietary supplementation. RESULTS: Compared to placebo, OFS decreased significantly serum aminotransferases, aspartate aminotransferase after 8 weeks, and insulin level after 4 weeks, but this could not be related to significant effect on plasma lipids. CONCLUSION: This pilot study supports the putative interest of OFS in the management of liver diseases associated with abnormal lipid accumulation in humans.
- Published
- 2005
5. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
- Author
-
UCL - MD/FARM - Ecole de pharmacie, UCL - SC/BIOL - Département de biologie, Cani, Patrice D., Daubioul, Catherine, Reusens, Brigitte, Remacle, Claude, Catillon, Grégory, Delzenne, Nathalie M., UCL - MD/FARM - Ecole de pharmacie, UCL - SC/BIOL - Département de biologie, Cani, Patrice D., Daubioul, Catherine, Reusens, Brigitte, Remacle, Claude, Catillon, Grégory, and Delzenne, Nathalie M.
- Abstract
We have evaluated the influence of oligofructose (OFS), a fermentable dietary fibre, on glucose homeostasis, insulin production and intestinal glucagon-like peptide-1 (GLP-1) in streptozotocin-treated diabetic rats. Male Wistar rats received either i.v. streptozotocin (STZ; 40 mg/kg) or vehicle (CT); one week later, they were fed for 6 weeks with either the standard diet (STZ-CT), or with a diet containing 10% oligofructose (STZ-OFS); both diets were available ad libitum. In a second set of experiments (duration 4 weeks), a supplemental group of food-restricted rats (STZ-Res) receiving a similar intake as CT rats, was added. OFS improved glucose tolerance and reduced food intake as compared with STZ-CT rats in both the post-prandial state and after an oral glucose tolerance test. After 6 weeks, portal and pancreatic insulin concentrations were doubled in STZ-OFS rats. Food restriction improved these parameters when compared with STZ-CT rats, but to a lesser extent than in the STZ-OFS group. We have shown that OFS treatment increased portal and colonic GLP-1(7-36) amide levels and doubled colonic proglucagon and prohormone convertase 1 mRNA levels; both OFS and food restriction lowered ileal GLP-1(7-36) amide levels as compared with levels in STZ-CT rats. We propose that OFS, through its fermentation in the colon, promotes the expression and secretion of colonic peptides, namely GLP-1(7-36) amide, with beneficial consequences on glycaemia, insulin secretion and hyperphagia in diabetic rats.
- Published
- 2005
6. Impact of inulin and oligofructose on gastrointestinal peptides
- Author
-
UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., Cani, Patrice D., Daubioul, Catherine, Neyrinck, Audrey M., UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., Cani, Patrice D., Daubioul, Catherine, and Neyrinck, Audrey M.
- Abstract
In the present paper, we summarise the data supporting the following hypothesis: dietary inulin-type fructans extracted from chicory root may modulate the production of peptides, such as incretins, by endocrine cells present in the intestinal mucosa, this phenomenon being involved in the regulation of food intake and/or systemic effects. To test this hypothesis, male Wistar rats received for 3 weeks either a standard diet or the same diet supplemented with 10 % inulin-type fructans with different degrees of polymerisation. All the effects were most pronounced with the diet containing oligofructose, and consisted of (i) a decrease in mean daily energy intake and in epididymal fat mass; (ii) a higher caecal pool of the anorexigenic glucagon-like peptide-1 (7-36) amide (GLP-1), and peptide YY (PYY), due to caecal tissue proliferation; (iii) an increase in GLP-1 and of its precursor - proglucagon mRNA - concentrations in the proximal colon; (iv) an increase in portal serum level of GLP-1 and PYY; (v) a decrease in serum orexigenic peptide ghrelin. Moreover, oligofructose supplementation improved glucose homeostasis (i.e. decreased glycaemia, increased pancreatic and serum insulin content) in diabetic rats previously treated with streptozotocin, a phenomenon that is partly linked to the reduction in food intake and that correlates with the increase in colic and portal GLP-1 content. Based on these results it appears justified to test, in human subjects, the hypothesis that dietary inulin-type fructans could play a role in the management of obesity and diabetes through their capacity to promote secretion of endogenous gastrointestinal peptides involved in appetite regulation.
- Published
- 2005
7. Involvement of GLP-1 (7-36) amide (GLP-1) in glycemia-lowering effect of oligofructose in streptozotocin diabetic rats
- Author
-
UCL - SC/BIOL - Département de biologie, UCL - MD/FARM - Ecole de pharmacie, Cani, Patrice D., Daubioul, Catherine, Neyrinck, Audrey M., Reusens, Brigitte, Remacle, Claude, Catillon, Grégory, Delzenne, Nathalie M., 15th International Symposium on Regulatory Peptides, UCL - SC/BIOL - Département de biologie, UCL - MD/FARM - Ecole de pharmacie, Cani, Patrice D., Daubioul, Catherine, Neyrinck, Audrey M., Reusens, Brigitte, Remacle, Claude, Catillon, Grégory, Delzenne, Nathalie M., and 15th International Symposium on Regulatory Peptides
- Published
- 2004
8. Influence de l'oligofructose sur le métabolisme glucidique et lipidique
- Author
-
UCL - MD/FARM/PMNT - Unité de pharmacocinétique, métabolisme, nutrition et toxicologie, Delzenne, Nathalie, Daubioul, Catherine, UCL - MD/FARM/PMNT - Unité de pharmacocinétique, métabolisme, nutrition et toxicologie, Delzenne, Nathalie, and Daubioul, Catherine
- Abstract
Les fructanes sont des glucides, naturellement présents dans certains aliments, qui, de part leur structure chimique échappent à l'hydrolyse par les enzymes digestives mais sont largement fermentés dans le caeco-colon. L'oligofructose (OFS) est un fructane obtenu par hydrolyse enzymatique de l'inuline, extraite à partir de racines de chicorée. De précédentes études ont permis de démontrer un effet hypotriglycéridémiant de l'OFS, résultant d'une moindre capacité de synthèse et d'estérification des acides gras dans le foie de rats Wistar. Au cours de ce travail, nous avons progressé dans la connaissance des effets physiologiques et/ou thérapeutiques de l'OFS, en nous focalisant sur son impact sur le métabolisme glucidique et lipidique. Les études ont été réalisées sur différents modèles de rats présentants ou non des altérations du métabolisme glucidique et lipidique, mais également chez l'homme. Nous avons tenté d'élucider, chez le rat, la nature des médiateurs permettant à ces glucides non digérés d'exercer des effets systémiques. Les résultats obtenus chez le rat contrôle Wistar normoglycémique et chez le rat Zucker fa/fa insulino-résistant, présentant une hyperglycémie modérée,ne nous permettent pas de soupçonner un éventuel effet de l'OFS sur la sensibilité à l'insuline, et suggèrent que l'OFS doit être présent dans le repas pour permettre une diminution de la glycémie. Par ailleurs, chez les rats traités à la streptozotocine, hyperglycémiques et hyperphagiques, l'OFS réduit la prise alimentaire, la glycémie, et restaure partiellement la teneur en insuline pancréatique. Les concentrations en GLP-1, hormone intestinale sécrétée en réponse à l'ingestion de nutriments, sont augmentées suite à l'addition d'OFS dans le régime du rat. Le GLP-1, via son effet sur la satiété et sur la prolifération des cellules B pancréatiques pourrait constituer un médiateur des effets observés chez le rat traité à la streptozotocine. Chez le rat obèse, l'ajout de fructane dans la nourr, Thèse de doctorat en sciences biomédicales (nutrition humaine) (SBIM 3) -- UCL, 2003
- Published
- 2003
9. Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats
- Author
-
UCL - MD/FARM - Ecole de pharmacie, Daubioul, Catherine, Rousseau, Nicolas, Demeure, Roger, Gallez, Bernard, Taper, Henryk, Declerck, Barbara, Delzenne, Nathalie M., UCL - MD/FARM - Ecole de pharmacie, Daubioul, Catherine, Rousseau, Nicolas, Demeure, Roger, Gallez, Bernard, Taper, Henryk, Declerck, Barbara, and Delzenne, Nathalie M.
- Abstract
This study was designed to compare the effects of dietary supplementation with nondigestible carbohydrates, differing in fermentability by colonic bacteria, on hepatic steatosis in growing obese Zucker rats. Male Zucker fa/fa rats were divided into three groups: a control group that received the basal diet, a fructan group that received 10 g highly fermented Synergy 1/100 g diet and a cellulose group that received 10 g poorly fermented Vivapur Microcrystalline cellulose/100 g diet. Rats consuming fructan had a lower energy intake, a lower body weight and less triacylglycerol accumulation in the liver as assessed in vivo by nuclear magnetic resonance (NMR) spectroscopy, and ex vivo by biochemical and histochemical analysis compared with the control and/or cellulose groups. The high fermentation of fructans compared with cellulose was reflected by greater cecal contents and by a twofold greater propionate concentration in the portal vein of rats fed fructan compared with those fed cellulose. By measuring the capacity of hepatocytes isolated from liver of Zucker rats to synthesize triglycerides or total lipids from different precursors, we showed that propionate, at the concentrations measured in the portal vein of rats treated with fructan, selectively decreased the incorporation of acetate into total lipids, a phenomenon that could contribute, along with the lower energy intake, to less triglyceride accumulation in the liver of obese Zucker rats fed dietary fructans.
- Published
- 2002
10. Inulin and oligofructose modulate lipid metabolism in animals : review of biochemical events and future prospects
- Author
-
UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., Daubioul, Catherine, Neyrinck, Audrey M., Lasa, M., Taper, Henryk, UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., Daubioul, Catherine, Neyrinck, Audrey M., Lasa, M., and Taper, Henryk
- Abstract
Inulin and oligofructose, besides their effect on the gastro-intestinal tract, are also able to exert 'systemic' effect, namely by modifying the hepatic metabolism of lipids in several animal models. Feeding male Wistar rats on a carbohydrate-rich diet containing 10 % inulin or oligofructose significantly lowers serum triacylglycerol (TAG) and phospholipid concentrations. A lower hepatic lipogenesis, through a coordinate reduction of the activity and mRNA of lipogenic enzymes is a key event in the reduction of very low-density lipoprotein-TAG secretion by oligofructose. Oligofructose is also able to counteract triglyceride metabolism disorder occurring through dietary manipulation in animals, and sometimes independently on lipogenesis modulation: oligofructose reduces post-prandial triglyceridemia by 50 % and avoids the increase in serum free cholesterol level occurring in rats fed a Western-type high fat diet. Oligofructose protects rats against liver TAG accumulation (steatosis) induced by fructose, or occurring in obese Zucker fa/fa rats. The protective effect of dietary inulin and oligofructose on steatosis in animals, would be interesting, if confirmed in humans, since steatosis is one of the most frequent liver disorders, occurring together with the plurimetabolic syndrome, in overweight people. The panel of putative mediators of the systemic effects of inulin and oligofructose consists in either modifications in glucose/insulin homeostasis, the end-products of their colonic fermentation (i.e. propionate) reaching the liver by the portal vein, incretins and/or the availability of other nutrients. The identification of the key mediators of the systemic effects of inulin and oligofructose is the key to identify target function(s) (or dysfunction(s)), and finally individuals who would take an advantage of increasing their dietary intake.
- Published
- 2002
11. Study of the regulation by nutrients of the expression of genes involved in lipogenesis and obesity in humans and animals.
- Author
-
UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., Ferré, P, Beylot, M, Daubioul, Catherine, Declercq, B, Diraison, F, Dugail, I, Foufelle, F, Foretz, M., Mace, K, Reimer, R, Palmer, G, Rutter, G, Tavare, J, Van Loo, J, Vidal, H., UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., Ferré, P, Beylot, M, Daubioul, Catherine, Declercq, B, Diraison, F, Dugail, I, Foufelle, F, Foretz, M., Mace, K, Reimer, R, Palmer, G, Rutter, G, Tavare, J, Van Loo, J, and Vidal, H.
- Abstract
Dietary digestible carbohydrates are able to modulate lipogenesis, by modifying the expression of genes coding for key lipogenic enzymes, like fatty acid synthase. The overall objective of the Nutrigene project (FAIR-CT97-3011) was to study the efficiency of various carbohydrates to modulate the lipogenic capacity and relevant gene expression in rat and human species (control and obese subjects) and to understand the underlying molecular mechanisms involved in the regulation of lipogenic genes by carbohydrates. Key cellular mediators (namely SREBP-1c and 2, AMP activated protein kinase, cholesterol content) of the regulation of lipogenic gene expression by glucose and/or insulin were identified and constitute new putative targets in the development of plurimetabolic syndrome associated with obesity. In humans, hepatic lipogenesis and triglyceride synthesis, assessed in vivo by the use of stable isotopes, was promoted by a high-carbohydrate diet in non obese subjects, and in non alcoholic steatotic patients, but was not modified in the adipose tissue of obese subjects. Non digestible/fermentable carbohydrates, such as fructans, were shown to decrease hepatic lipogenesis in non obese rats, and to lessen hepatic steatosis and body weight in obese Zucker rats. If confirmed in obese humans, this would allow the development of functional food able to counteract the metabolic disturbances linked to obesity.
- Published
- 2001
12. Dietary fructans and lipid metabolism : building a bridge from the colon to the liver
- Author
-
UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., Daubioul, Catherine, UCL - MD/FARM - Ecole de pharmacie, Delzenne, Nathalie M., and Daubioul, Catherine
- Abstract
Several non digestible but fermentable dietary carbohydrates, besides their effect on the gastrointestinal tract, are also able to exert systemic effect, namely by modifying the metabolism of lipids. The present review aims at illustrating how specific fermentable carbohydrates, namely dietary fructans, escaping the hydrolysis by amylases or disaccharidases, highly fermented in the caeco-colon by gramnegative bacteria, are susceptible to influence fatty acid metabolism and lipemia in experimental animal models, but also in humans. By focusing on the effect of oligofructose or inulin, which are dietary fructans obtained from chicorey roots, we illustrate here that the hepatic metabolism of fatty acids seems to be a relevant goal of fructans. The panel of the putative mediators of the systemic effects of fructans are presented and discussed, and consist in either 1) modifications in glucose/insulin homeostasis 2) the end-products of colonic fermentation of fructans, reaching the liver by the portal vein and /or 3) intestinal hormones and /or 4) other nutrients availability.
- Published
- 2001
13. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats
- Author
-
UCL - MD/FARM - Ecole de pharmacie, Daubioul, Catherine, Taper, Henryk, De Wispelaere, Laurent D., Delzenne, Nathalie M., UCL - MD/FARM - Ecole de pharmacie, Daubioul, Catherine, Taper, Henryk, De Wispelaere, Laurent D., and Delzenne, Nathalie M.
- Abstract
We studied the influence of oligofructose (OFS), a nondigestible fructan, on lipid metabolism in obese fa/fa Zucker rats. The addition of 10 g/100 g OFS to the diet slowed the increase in body weight without modifying serum triglycerides or glucose concentrations after 7 wk of treatment. However, an oral load of 2 g glucose and 5 g corn oil/kg body weight increased triglyceridemia more in OFS-fed rats than in control rats. After 10 wk, OFS decreased the hepatic concentration of triglycerides 57% relative to controls. The less severe steatosis was confirmed by histologic analysis. Among the key enzymes involved in fatty acid synthesis and esterification, only malic enzyme activity was significantly lower in OFS-fed rats than in controls. The epididymal fat mass was significantly lower in OFS-fed rats. In conclusion, dietary enrichment with OFS can counteract both the fat mass development and the hepatic steatosis that occur in obese Zucker rats. Future studies will be designed to clarify in obese animals the influence of dietary OFS on postprandial triglyceridemia, which is an important variable associated with the development of atherosclerosis in humans, and to analyze the biochemical mechanism underlying the "hepatoprotective" effect of OFS.
- Published
- 2000
14. Involvement of endogenous glucagon-like peptide-1(7–36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats
- Author
-
Cani, Patrice D, primary, Daubioul, Catherine A, additional, Reusens, Brigitte, additional, Remacle, Claude, additional, Catillon, Grégory, additional, and Delzenne, Nathalie M, additional
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.